BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abd ElWahab M, El Nakeeb A, El Hanafy E, Sultan AM, Elghawalby A, Askr W, Ali M, Abd El Gawad M, Salah T. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg 2016; 8(6): 436-443 [PMID: 27358676 DOI: 10.4240/wjgs.v8.i6.436] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Q, Guan Y, Mao L, Zhu Y, Chen J, Shi J, Tang M, Qiu Y, Zhu B, He J. Modification and establishment of CT criteria in preoperative assessment of portal venous invasion by hilar cholangiocarcinoma. HPB 2018;20:1163-71. [DOI: 10.1016/j.hpb.2018.05.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhou Q, Dong G, Zhu Q, Qiu Y, Mao L, Chen J, Zhou K, Hu A, He J. Modification and comparison of CT criteria in the preoperative assessment of hepatic arterial invasion by hilar cholangiocarcinoma. Abdom Radiol (NY) 2021;46:1922-30. [PMID: 33159559 DOI: 10.1007/s00261-020-02849-0] [Reference Citation Analysis]
3 Birgin E, Rasbach E, Reissfelder C, Rahbari NN. A systematic review and meta-analysis of caudate lobectomy for treatment of hilar cholangiocarcinoma. Eur J Surg Oncol 2020;46:747-53. [PMID: 31987703 DOI: 10.1016/j.ejso.2020.01.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Miyata T, Okabe H, Chikamoto A, Yamao T, Umezaki N, Tsukamoto M, Kitano Y, Arima K, Nakagawa S, Imai K, Hashimoto D, Yamashita YI, Baba H. A long-term survivor of hilar cholangiocarcinoma with resection of recurrent peritoneal dissemination after R0 surgery: a case report. Surg Case Rep 2017;3:110. [PMID: 29039079 DOI: 10.1186/s40792-017-0386-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Tran TB, Ethun CG, Pawlik TM, Schmidt C, Beal EW, Fields RC, Krasnick B, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Idrees K, Isom CA, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA. Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma. Ann Surg Oncol. 2019;26:611-618. [PMID: 30539494 DOI: 10.1245/s10434-018-7075-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
6 Jung JH, Lee HJ, Lee HS, Jo JH, Cho IR, Chung MJ, Park JY, Park SW, Song SY, Bang S. Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma. World J Gastroenterol 2017; 23(18): 3301-3308 [PMID: 28566890 DOI: 10.3748/wjg.v23.i18.3301] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
7 Yang M, Li WW, Chen JH, Cui MH, Liu JL. The value of caudate lobectomy in hilar cholangiocarcinoma treatment: A meta-analysis. Medicine (Baltimore) 2021;100:e24727. [PMID: 33607815 DOI: 10.1097/MD.0000000000024727] [Reference Citation Analysis]